Cerus (CERS) Metrics: History & Chart

Cerus Corporation(CERS)

Medical - Devices · Concord, CA

$2.33-0.01 (-0.58%)

Delayed quote: Oct 6, 2026, 10:15 AM EDT

About Cerus Corporation

Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens. The company's product line includes INTERCEPT systems specifically engineered to deactivate pathogens in donated platelets and plasma. It also offers a dedicated INTERCEPT Blood System for the inactivation of harmful agents in red blood cell components. Furthermore, Cerus markets an INTERCEPT Blood System for Cryoprecipitation, which leverages its plasma technology to produce two key pathogen-reduced blood products: a cryoprecipitated fibrinogen complex for treating and controlling bleeding, particularly massive hemorrhages stemming from fibrinogen deficiency, and pathogen-reduced, cryoprecipitate-reduced plasma. Cerus distributes these platelet and plasma systems globally through a combination of its direct sales force and an extensive network of distributors, reaching markets in North America, Europe, the Commonwealth of Independent States, the Middle East, and Latin America. Established in 1991, Cerus Corporation maintains its corporate headquarters in Concord, California.

Concord, CA

268 employees

www.cerus.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Vivek K. Jayaraman

View full financials

Third-Party DCF Estimate (FMP)	$2.61
Price Gap vs Third-Party Estimate	+11.70%

7D Total Return	-4.49%
30D Total Return	-9.65%
YTD Total Return	+13.59%
1Y Total Return	+49.04%
3Y Total Return	+65.96%
5Y Total Return	-61.31%
10Y Total Return	-62.61%
15Y Total Return	+0.90%
20Y Total Return	-62.69%

2026	+13.59%
2025	+33.77%
2024	-28.70%
2023	-40.82%
2022	-46.40%
2021	-1.59%
2020

CAGR TTM	+48.76%
CAGR 3Y	+18.39%
CAGR 5Y	-17.30%
CAGR 10Y	-9.37%
CAGR 15Y	+0.06%
CAGR 20Y	-4.81%

PE Ratio	12.48
PE Ratio Avg TTM	20.76
PE Ratio Avg 3Y	20.76
Current VS TTM Avg	-39.88%
Current VS 3Y Avg	-39.88%
Current VS 5Y Avg	-39.88%

All Metrics

CERS Valuation Metrics

CERS Stock Price Metrics

CERS Dividend Metrics

CERS Growth Rate Metrics

CERS Discounted Cash Flow Metrics

CERS Returns By Period

CERS Yearly Returns

CERS Average Annual Returns By Period (CAGR)

CERS Revenue Metrics

CERS PE Ratio Metrics

CERS PS Ratio Metrics

CERS PB Ratio Metrics

CERS Price to Free Cash Flow Ratio Metrics

CERS Debt to Equity Ratio Metrics

CERS PEG Ratio Metrics

CERS FCF Yield

CERS Earnings Yield

CERS EBITDA Yield

CERS OCF Yield

CERS EV/EBIT Ratio Metrics

CERS EV/EBITDA Ratio Metrics

CERS EV/Assets Ratio Metrics

CERS EV/Sales Ratio Metrics

CERS Current Ratio Metrics

CERS Quick Ratio Metrics

CERS ROIC Metrics

CERS Return on Assets Metrics

CERS Return on Equity Metrics

CERS Net Profit Margin Metrics

CERS Gross Profit Margin Metrics

CERS Tax Rate Metrics

PS Ratio	2.12
PS Ratio Avg TTM	2.12
PS Ratio Avg 3Y	1.95
Current VS TTM Avg	+0.17%
Current VS 3Y Avg	+8.81%
Current VS 5Y Avg	-20.40%

PB Ratio	6.70
PB Ratio Avg TTM	6.83
PB Ratio Avg 3Y	6.34
Current VS TTM Avg	-1.89%
Current VS 3Y Avg	+5.76%
Current VS 5Y Avg	-9.13%

PFCF Ratio	351.97
PFCF Ratio Avg TTM	826.37
PFCF Ratio Avg 3Y	710.39
Current VS TTM Avg	-57.41%
Current VS 3Y Avg	-50.45%
Current VS 5Y Avg	-50.45%

Debt/Equity Ratio	1.10
Debt/Equity Ratio Avg TTM	1.49
Debt/Equity Ratio Avg 3Y	1.77
Current VS TTM Avg	-26.19%
Current VS 3Y Avg	-37.96%
Current VS 5Y Avg	-27.21%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.28%
FCF Yield Avg TTM	1.11%
FCF Yield Avg 3Y	1.42%
Current VS TTM Avg	-74.76%
Current VS 3Y Avg	-80.35%
Current VS 5Y Avg	-80.35%

Earnings Yield	8.02%
Earnings Yield Avg TTM	5.12%
Earnings Yield Avg 3Y	5.12%
Current VS TTM Avg	+56.76%
Current VS 3Y Avg	+56.76%
Current VS 5Y Avg	+56.76%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	8002.14
Ev/Ebitda Ratio Avg TTM	8683.24
Ev/Ebitda Ratio Avg 3Y	8683.24
Current VS TTM Avg	-7.84%
Current VS 3Y Avg	-7.84%
Current VS 5Y Avg	-7.84%

Ev/Assets Ratio	2.57
Ev/Assets Ratio Avg TTM	2.39
Ev/Assets Ratio Avg 3Y	2.13
Current VS TTM Avg	+7.35%
Current VS 3Y Avg	+20.65%
Current VS 5Y Avg	+0.73%

Ev/Sales Ratio	2.38
Ev/Sales Ratio Avg TTM	2.48
Ev/Sales Ratio Avg 3Y	2.38
Current VS TTM Avg	-3.84%
Current VS 3Y Avg	-0.03%
Current VS 5Y Avg	-21.98%

Current Ratio	1.83
Current Ratio Avg TTM	1.82
Current Ratio Avg 3Y	2.10
Current VS TTM Avg	+0.92%
Current VS 3Y Avg	-12.79%
Current VS 5Y Avg	-14.87%

Quick Ratio	1.07
Quick Ratio Avg TTM	1.19
Quick Ratio Avg 3Y	1.48
Current VS TTM Avg	-10.29%
Current VS 3Y Avg	-27.77%
Current VS 5Y Avg	-34.19%

ROIC	(1.08%)
ROIC Avg 3Y	(10.06%)
ROIC Avg 5Y	(17.23%)
Current VS 3Y Avg	+89.25%
Current VS 5Y Avg	+93.72%
Current VS 10Y Avg	+96.67%

ROA	(3.31%)
ROA Avg TTM	(1.17%)
ROA Avg 3Y	(2.42%)
Current VS TTM Avg	-183.38%
Current VS 3Y Avg	-36.66%
Current VS 5Y Avg	+7.25%

ROE	(9.69%)
ROE Avg TTM	(21.64%)
ROE Avg 3Y	(46.45%)
Current VS TTM Avg	+55.22%
Current VS 3Y Avg	+79.14%
Current VS 5Y Avg	+81.95%

Net Profit Margin	(3.06%)
Net Profit Margin Avg TTM	(4.57%)
Net Profit Margin Avg 3Y	(11.18%)
Current VS TTM Avg	+33.11%
Current VS 3Y Avg	+72.64%
Current VS 5Y Avg	+84.23%

Gross Profit Margin	52.05%
Gross Pft Margin Avg TTM	52.71%
Gross Pft Margin Avg 3Y	54.15%
Current VS TTM Avg	-1.25%
Current VS 3Y Avg	-3.88%
Current VS 5Y Avg	-3.52%

Tax Rate	130.77%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A